Skip to search formSkip to main contentSkip to account menu

LY 281067

Known as: LY281067 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Background —Mild oxidation of LDL enhances its atherogenic potential and induces a synergistic interaction with serotonin (5HT… 
1999
1999
Highly Cited
1997
Highly Cited
1997
BACKGROUND Restenosis is a major complication that limits the long-term efficacy of coronary angioplasty. Migration and… 
1989
1989
The ergoline esters, LY53857 [6-methyl-1-(1-methylethyl)ergoline-8-carboxylic acid 2-hydroxy-1-methylpropylester (Z)-2… 
1988
1988
The preclinical pharmacologic activity of LY281067 shows it to be a potent and highly selective serotonergic (5-HT2) receptor…